Previous 10 | Next 10 |
2023-12-29 08:28:03 ET More on Microbot Medical Microbot to advance Liberty Robotic System into pivotal clinical trial Seeking Alpha’s Quant Rating on Microbot Medical Historical earnings data for Microbot Medical Financial information for Microbot Med...
2023-12-29 08:21:40 ET Microbot Medical ( MBOT ) -27% after announces exercise of outstanding preferred investment options for $2.73 million. Ucommune International ( UK ) -21% . SenesTech ( SNES ) -20% . Cingulate ( CING ) -20% . Bone B...
BRAINTREE, Mass., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding preferred investme...
2023-12-28 13:01:35 ET Gainers: Sidus Space ( SIDU ) +193% . Cingulate ( CING ) +167% . Nova Lifestyle ( NVFY ) +146% . Jin Medical International ( ZJYL ) +58% . Ucommune International ( UK ) +53% . Microbot Medical ( MBOT ...
2023-12-28 12:22:59 ET DENVER, Colo., Dec. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; SEALSQ Corp (NASDAQ: LAES), Microbot Medical Inc (NASDAQ: MBOT), Nova Lifestyle Inc (NASDAQ: NVFY), Se...
2023-12-28 10:07:56 ET DENVER, Colo., Dec. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; SEALSQ Corp (NASDAQ: LAES), Microbot Medical Inc (NASDAQ: MBOT), Absci Corp(NASDAQ: ABSI), Nova Lifestyle Inc...
2023-12-28 09:05:05 ET More on Microbot Medical Seeking Alpha’s Quant Rating on Microbot Medical Historical earnings data for Microbot Medical Financial information for Microbot Medical For further details see: Microbot to advance Liberty Robotic S...
BRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under the guidelines of FDA-required...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...
News, Short Squeeze, Breakout and More Instantly...
Microbot Medical Inc. Company Name:
MBOT Stock Symbol:
NASDAQ Market:
Microbot Medical Inc. Website:
BRAINTREE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announces it has received Institutional Review Board (IRB) approval and signed a clinical trial agreement with Memor...
Baptist Hospital of Miami is the second site to perform clinical procedures as part of the Company’s Pivotal Human Clinical Trial. The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular R...
The first clinical case was performed at Brigham and Women’s Hospital The clinical trial is expected to support the future submission to the FDA for the commercialization of the LIBERTY ® Endovascular Robotic Surgical System BRAINTREE, Mass., July 08, 2024 (G...